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The moiecuiar and cellular process~% underlying photoreceptor degeneration in rctinitis pigmcntosa (RP) are unknown. WC have investigated gene 
expression in diseased retinas using differential hybridization screening of a retinal cDNA library with probes derived from normal and RP retinal 
RNA. Most differential clones detected cormpondcd to transcripts absent from the dystrophic state, including e.g. opsin. However, one clone was 
noticeably increased in RP in comparison with the control: partial sequencing showed it encoded clusterin. Increased cxpmsion of ciustcrin has 
been identified in scvcral cases of tissues undergoing apoptosis (programmed cell death), and our finding suggests that the dcgenerativc changes 
in advanced RP may represent another cxampie of apoptosis. possibly with common causative mechanisms. 
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1. INTRODUCTION 
Retinitis pigmentosa (RP) iy ’ b term for a heter- 
ogeneous group of inheritable retinal diseases in which 
degeneration of the photoreceptor cells results in night 
blindness and progressive contraction of the visual 
fields. The diseases, which together affect 1-2 in 5,000 
of most populations tudied, may be transmitted in au- 
tosomal dominant, autosomal recessive, and X-linked 
modes [I]. Sporadic (simplex) cases also occur. The ge- 
netic defects responsible for a number of autosomal 
dominant cases have been identified: the majority arc 
point mutations distributed through the coding region 
of the gene for the visual pigment protein, rhodopsin, 
but display no obvious relationship between altered 
amino acid residue and the known functional signifi- 
cance of rhodopsin structure [2-4]. Mutations in other 
genes expressed in the photoreceptors, including peri- 
pherin, have also been associated with dominant RP 
[5.6]. In spite of the rapidly increasing identification of 
RP-associated mutations, however, the links bctwccn 
the genetic faults and the molecular and cellular proc- 
esses which result in photoreceptor degeneration i all 
types of RP remain poorly understood. 
Insight into the pathology of R.P may bc gained by 
an z:~lysis of the transcriptional ctivity in discascd 
retinas. WC have previously reported RP-related abnor- 
malities in the expression of specific retinal mRNAs by 
Northcm blot and in vitro translation malysis [?I. Hcrc 
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WC describe an extinction of these studies by the use of 
differential screening of a retinal cDNA library with 
cDNA probes derived from normal and RP RNA, and 
discuss the significance of abnormally expressed genes 
in the dystrophic retina in relation to possiiile mecha- 
nisms of cellular degeneration. 
2. EXPERIMENTAL 
Normal human eyes wcrc obtained through the UK Transplant 
Service. Bristol. Enucleatcd cycs were dissected and the retinas rc- 
moved; thcsc were stored frozen in liquid nkrogen until RNA cxtrac- 
tion. Dystrophic retinas wcrc frozen in liquid nitrogen through the UK 
RP Eye Donor Schcmc. The post-mortem intcrvai (pmi) belwccn 
death and freezing was recorded in each case. RNA was extracted 
from the retinas of 3 donors with ocular diceasc. two of whom had 
rctinitis pigmentosa (DYSZ and DYS3). and a third who had hcre- 
ditary optic atronhy (DYSI): 
Donor DYSi. Pcmalc. age 55 years, pmi not > 24 h. Hereditary 
optic atrophy, based on medical history: normal dark adaptation and 
no pigmcntary abnormalities of retina. Daughter also alfectcd. 
Doaur DYSZ: MaJc, age 65 years. pmi = 22 h. Father known RP 
suRcrcr. Son (only child, age 30 years) normal. Probable autosomal 
dominant RP with rcduccd pcnctrancc. 
Donor D YS.3: Malt. age 81 ycan. pmi = 32 h. No history ol’visuai 
disorder in family. Probahlc simplex RP. 
RNA was also cxtnctcd from the rctinar, of 4 normal donob with 
no known history of cyc disease: 
Dfrttot CONI: Malt. age 54 years. pmi = 26 h. 
Dunor CON? Malt, age 64 years, pmi = 25 h. 
Dtmur CON3: Male. age 70 years. pmi = 38 h. 
&nor C0N4. Malt. age 72 years. pmi = 33 h. 
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Fig. 1. Southern blot ol &coRMigcstcd DNA isolated tiom d~ftcren- 
tially-rxprcsscd clones, probes with y-“P-labcelled oligonucleutidc 
probe complcmcntaq to human opsin. Lanes l-6: clones K I I I, 41 I, 
51 I 554.61 I and 661. rcspcctivcly. Four six markers arc shown. The 
upper hybridiring bands corrc3pond to residual undigcstcd rccom- 
hinant DNA. 
thcsc. 5 gave strong signals with the control probe and 
weak or absent signals with the RP probe. Since it is the 
photoreceptor cells that are primarily affected in RP, it 
is probable that thcsc clones correspond to messenger 
RNAs cxpre:shed mainly in this layer. although altered 
expression in other neural layers cannot be excluded. 
Support for the forrncr possibility was obtained by 
probing a Southern blot of the inserts with a labclled 
oligonuslcootide probe specific for human ;Isin: two 
clones (K I i 1 and K554) contained compicmentary sc- 
qucnccs (Fig. I). Two other clones (KS11 and K611) 
cross-hybridized with tt . olignnuclcotidc probe for S- 
antigen (not shown). which is another gene abundantly 
cxprcsscd in photoreceptors. A fi.‘th clone (K411). not 
dctcctcd by these probe, whose insert was obtained by 
PCR amplification using vector spccitic primers. was 
used io pr&c a Northern blot of retinal RNAs (Fig. Za!. 
It dctcctcd an abundant transcript of approximately 2.0 
kb. and ;L faint. possibly precursor transcript in 3.0 kb. 
in normal retinal RNA. Thcsc transcripts bcrc com- 
pletely ;~trsi-nt from the retinal RNA of the two casti of 
;~dvan~rcl RP (donors DI’S2 and DYS3) but WLTC 
cloclrl> dctayablc in the c’;t’ti’ of optic atrophy (donor 
DYSI ). Whm the blol \%;I\ hybridized Gth 9 cDNA 
proix ~XL%C liar ati’t~!t. h;lnus of Grntbr intcnsit) corrc- 
sponrlmg to nranwtipas or appro*irWcl> 1.3 kb WLYC 
&WX%X! it. wch RSA a;bmplc. iradiz&ing tbt the dtf- 
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Fig. 2. North':m blot of normal and dystrophic total retinal RNA (3 
pg per lane) pi obed with 0~-~"P-labelted differential and control cD~ ~\ 
probes. Lanes | -6: RNA Erom donors CON1, DYSt, CON2, DYS2, 
CON3, DYS3, respectively, Probes: (it) K411 {opsinl; (b) K661 (elus- 
terin) and 1¢1 actin, washed Io stringencies of (a) ! x SSPE, 0.1% SDS. 
65°C; (b) 2 x SSPE, 0.1% SDS, 42°C; (c) I xSSPE, 0.1% SDS, 42°C. 
(I × SSPE is 0,t8 M NaCI, 10 mM sodium phosphate pH 7.?. i mM 
disodium EDTA.) The actin signal (c) is rdalively reduced owing to 
repe~lted reprobing and strippi.~g of the blot, 
ferences in expression of the K411 transcripts were not 
due to variation in sample loading or integrity (Fig 2c). 
Subcloning and partial sequencing of K411 showed that 
it also encoded human opsin. The lack of opsin mRNA 
expression in advanced RP supports our previous ob- 
servations of reduced opsin in in vitro translation prod- 
uct from RP retinal RNA [7], and presumably reflects 
the substantial loss of photoreceptors from the diseased 
relinas. In contrast, the case of optic atrophy shows 
essentially normal expression of opsin mRNA, concor- 
dant with the normal dark-adaptation seen in this donor 
shortly before her death, and suggests that she had re- 
tained a largely intact population of photoreceptors. 
A filrther clone (K661) gave moderately strong sig- 
nals with the control sscDNA probe, but stronger sig- 
:~a!s with the RP probe Di~3¢~tit~. with Ec.RI released 
two fragments, of 850 and 170 bp. Use of the larger 
fragment as a probe on the Northern blot of retinal 
R NA detected it major abul~dant transcript of approxi- 
m:!!e!y 1,8 kb present in both normal and RP RNA: a 
ntinor, poszible pret-ursor mRNA at 3,6 kb was ~,;so 
visible in some lanes on the origi.al autoradiograph 
(Fig. 2b). Stronger signals were seen with both cases of 
advanced RP (donors DYS2 and DYS3) than with the 
controls, confirming the differential screening result. 
Again. with the case or optic atrophy (DYS1). expres- 
sion of this gent approximated normal levels. Both 
EcoRl fragments of K661 were subcloned into M 13 and 
sequenced wholly or partially. Comparison of the se- 
quences with the EMBL and GenBank databases 
showed that both contained parts of  the coding se- 
quence of the human clusterin gene 1>99.5% identity: 
differences assumed to be cloning artifacts), known var- 
iously, also. as SP-40.40. complement lysis inhibitor 
(CLI). sulphated glycoprotein 2 (SGP-2). testosterone- 
repressed message-2 (TRPM-2). and apolipoprotein J 
[16-20]. The size of the major retinal transcript is in 
agreement with repor.'s of mRNAs of human clusterin 
in other tissues (1.9-2.0 kb [20.2t ]). Internal cleavage of 
the K661 insert had occurred at the EcoR! site at base 
856 of the published sequence ofclusterin (as SP-40.40) 
[16]. 
Clusterin is a 70-80 kDa sulphated glycoprotein com- 
prised of two nonidentical polypeptides of Mr 40.000 
linked by disulphide bonds. The polypeptides are pro- 
teolytically derived from a precursor protein translated 
from a single mRNA transcript [16]. Clusterin is present 
at concentrations o£ 50-100 pg/ml in normal human 
plasma and at about 10-fold higher concentrations in
seminal plasma, and is expressed in a variety of tissues 
[16-18]. Our report describes the first observation of 
clusterin mRNA expression in retina, and the strength 
of hybridization signal on the Northern blot indicates 
it is a highly abundant ranscript even in the no~mal 
tissue. Clusterin is assumed to be multifunctional, and 
in blood associates with components ol'the complement 
system [17]; it also appears to interact with apolipo- 
protein AI, suggesung possible involvement in lipid 
transport [20,22]. Most significantly for our oxen obser- 
vations, an increase in expression ofcl,~sterin mRNA or 
protein has been observed in severa| instances of tiss,'e ~ 
undergoing p' grammcd cell death (apoptosi~) t|~-2-' 
25]. The increase in clusterin expression in the retinas 
of patients with advanced RP suggests that the associ- 
ated photorcceptor degeneration may be another in- 
stance of programmed cell death, possibly with molecu- 
lar and cellul.,r mechanisms in common with these re- 
ported examl,!,'~. 
Apoptotic events characteristically include endonu- 
clease-induced fragmentation of gcnomic DNA into nu- 
clcosomal unit oligomers, foUowcd by irreversible mor- 
phological changes, including nuclear disintegration. 
cell surface blebbing, and cellular fragmental|on i to a 
clusler o1 mcmbr:ulc-bound apoptoti¢ bodies 126]. 
While nttclc;t| I)NA ch;=-gcs h,~c. Io our kt~:~ledgc. 
11¢,~'¢r hccn cxltnlillcd H~ 't'. tdlr;~,,lrut:lBr;ll studio,, of 
RP retinas showy, in a¢ldtt ton to  photorc,ceptot Joss. se- 
vert membr;tnotts di,~lortion -'rod ~.esict|JatioB, I¢,,ICti~;C 
2,~: I 
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g&& of jifuller cck and \atibl>. autophagcqlic 
bm& epirecinal IUCIII~~~~~ formation. ad txfetive 
&~US~ular~tSintkregiOtl 
of &u&k membra.ne C728]]. we have pm4ousw 
~~~thattheglioticp~iaRPislinkedtoan 
incre;lst in -II of the mRNA for the intermedi- 
ate Glament compoaeut and @ial Deli marltet. @id fi- 
bd+ &d&z protein (GFAP) (7’J. It is possiiie that 
ek-ated dusterin eqwession is also associated with dial 
pmlikmtioti or activity. either as a IPsult of the in- 
- tzamiitim of this cell qpe to the total tissue 
mass of the degenerate retina, or as a specific intmeUu- 
lar in- in response to the adjacent dystrophic phc+ 
toreceptor C&L In this regard observations of the con- 
comitant elevation of clusterin and GFAP tnRN A levels 
in .Qheimer4seased hippocampus [21]. and of similar 
transcriptional changes in the hippocampus of cajtzated 
rats 1291. are of particular rekvance. Further. McNeil1 
et al. [30] detected the clusterin homologue, SGP-2. in 
the degenerating dentate gyms of adrenalectomized 
rats, as punctate deposits in the molecular layer, and in 
the glial cells juxtaposed to surviving neurons, but not 
in the granule neurons exhibiting signs of degeneration. 
SGP- 2 was not detected in corresponding brain regions 
of intact rats or adrenalectomized rats not showing 
granule cell loss. 
At least 3 possible roles for elevated clustct-in cxprcs- 
sion in tissue degeneration may bc hypothesized (see 
also c-g. [22,30]): (i) a direct causal involvement in the 
cascade of events leading to apoptosis in the cells where 
clusterin ttimsription increases: (ii) an ‘anti-suicide’ ac- 
tion. as a response of the ccl1 to retard the committed 
probrcssion of the cell death program; or (iii) a response 
not of the dying cclk but of their immc&ttc ncighbour5. 
possibly as part of a repair or tissue remodclling mcch- 
anism. We sugxst that the parallel molecular and ccl- 
lular changes in gh31 c&s in ncurcxicgcnoratiw states. 
including perhaps advanced RP. may correlate most 
CIOSC~~ Ah h>poth& (iii). In tke casts. the @ia. 
which arc gtzerally regarded as important supportive 
ckments of neurons. may uprezulatc clustcrin cxpnrs- 
sion to suppkmcnt its activity possibly as a lipid SW- 
wnger to redistribute or recycle lipid mUnbGinc com- 
wonen I??!. 3r as a transporrm of lipids. Xnalysis of 
norma! and degenerating retinas, ixcluding in situ and 
immunocgoch~ical approachn. is in progreu: 10 help 
resolw these qmtions. 
REFERENC’ES 
i:] Hcskcnlix~. J.R. (1988) R&nit& Pigment- J-B. LipFincolt 
Co, Iwadclphi 
A Dqja. T-I’, McGee. T.L., Rcichel, E, Hahn. L-B, Cow& G.S.. 
Yan&zlL D-W, Sandberg. MA. and Berson, EL. (1990) Nature 
343. x4-366 
13) Sung. C.-W.. Davenport. CM, Hennessey. J.C. Maumcncc. 
LH, Jacobson. S_G., Hcckcnliwly, J.R., Nowakouski. R.. Fish- 
man, G.. Gouras P. and Nathans, J. (1991) Proc. NatL Acad. Sci. 
USA 88,6481-6%5. 
[a] Ingleheanr. C.F_ Bashit. R.. Lester. D-H., Jay, M., Bird, A.C. 
and Bhattachaqa S. (1991) Am. J. Hum. &net. 48.2630. 
[5l Farrar. GJ.. Kenna. P.. Jordan. S-A.. Kumar-Singh. R.. Hum- 
phrics. M-M.. Sharp. E.M.. Sheils. D.M. and Humphrics, P. 
(1991 I Nature 354,478-4%X 
[6] Kajiwra, K.. Hahn, L.B.. Mukai. S..Tratis. G.H.. Berson. E.L. 
and Dryja. T.P. (1991) Nature 354,48&%3. 
[7] Jones. S-E.. Wood-Gush H.G.,Cunningham. J.R.. Szczesny. P.J. 
and NcaL MJ. (1990) Ncurochem. tnt. 17.495-503. 
IS] Chirgwin. J.M.. wbyla. A.E.. MacDonald, R.J. and Rutter, 
WJ. (1979) Biochemistry IS, 5294-5299. 
191 Sambrook. J.. Fritsch. E.F. and Maniatis, T. (1989) Mulccula- 
Cloning: A Laboratory Manual (2nd cd.), Cold Spring Harbor 
taboratory Press, New York. 
[to] Leonard, D.G.B.. ZilT, E.F. and Greene, L.A. (1987) Mol. Ccl1 
Biol. 7. 3156-3167. 
[l 11 Nathans. J. and Hogncss. D.S. (1984; Proc. Natl. Acad. Sci. USA 
81.4851-4855. 
(121 Yamaki, K., Takahashi. Y., Sakuragi, S. and Matsubara, K. 
(1987) Biochcm. Biophys. Rcs. Commun. 142,904-910. 
[I31 Meinkoth. J. and Wahl. G. (1984) Anal. Biochcm. 138.257-284. 
[14] Sangcr. F.. Nicklen. S. and Coulson, A.R. (1977) Proc. Natl. 
Acad. Sci. USA 74, 5463-5467. 
[I -51 Thomas. P.S. i 19801 Proc. Natl. Acad. Sci. USA 77.5201~5205. 
1161 Kirszbaum, L.. Eharpc. J.A., Murphy. B.. d’Apicc, A.J.F.. Clas- 
son. 6.. Hudson. P.and Walker. 1.D. (1989) EMBOJ. 8.71 I 718. 
111 Jmnc, D.E. and Tschopp. J. (1989) Proc. Natl. Acad. Sci. USA 
86.7123- 7127. 
[iri] Collard. M.W. and Griswold. M.D. (1987) Biochemistry 26. 
3297 3303. 
[lY( Lcgcr. J.G.. hlontpctif. M.L. and Tcnniswood. M.P. (19Y?) Bio- 
chcm. HiophFs. RL?. Cummun. 147. IO& 203. 
[XI] dc Silva. H.V., Harmony. J.A.K.. Stuart. W.D.. Gil. C.M. and 
Robhins. J (1990) Biochem;z@ 29. 5380 4389. 
12 1 I Dugwd. J .K.. Bohmont. C.W., Lw. N. and Tourtcllotru, W. W. 
(1989) Pmt. Natl. Acad. Sci. USA 86. 726&7264 
1221 Jc-nnc. D.E.. Lowin. B., Pcrtxh. MC.. Bottcher. A.. Schrr.!!?. c>. 
and Tschopp, J. (1991) J. Biol. Chem. 266. 1103&l 1036. 
[23) Kyprianou. N.. English. H.F.. Dzvidkon. N.E. and Iwcs. J.T. 
1 I$91 J Cancer RLX 51, 1;~ I66 
IX] Bcttuzzi. S.. Hiipakh. R.A.. Gilna. P. and Liao. S. (1989) Bio- 
chcm. J. 257. 291~,2. 
1251 Scmibx. J.A.. Griswold. M.D.. S~lvwcr. S.R.. Buttyan, R., 
Bardin. c’.\V.. Chcnp C.Y . . Dudck. S. and Lee. C. ! 1991) Endo- 
crmolo~~ IX 2091-1102. 
[26] Km, J.F.R.. Wyltic. A.H. and Curric. A.R. f 1972) Br J. Cancer 
2s. 239.255. 
